EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Open-Source Molecular Docking and AI-Augmented Structure-Based Drug Design: Current Workflows, Challenges, and Opportunities

Faizul Azam iD, Suliman A Almahmoud

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27073302 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Faizul Azam und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Drug Design, Artificial Intelligence. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 267 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Graduate Studies and Scientific Research at Qassim University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Molecular docking is a foundational technique in computational drug discovery, widely used to generate binding hypotheses, prioritize compounds, and support target-selectivity studies. The continued growth of open-source docking resources, together with improvements in scoring functions, sampling strategies, and hardware acceleration, has substantially lowered barriers to teaching, early-stage hit identification, and reproducible research. Beyond standalone docking engines, the open-source ecosystem now encompasses browser-accessible tools, preparation and analysis utilities, integrative modeling platforms, and AI-augmented methods for pose prediction, rescoring, and virtual screening. These developments have made docking workflows more accessible, customizable, and transparent across diverse research settings. This review examines open-source docking from a workflow-centered perspective, spanning study design, structural-data acquisition, binding-site definition, receptor and ligand preparation, docking execution, and post-docking validation. It further evaluates how open AI methods are being incorporated into these stages to expand structural coverage, improve screening efficiency, and support contemporary structure-based drug design. Collectively, this review outlines a practical and evidence-based framework for the effective use of open-source docking and virtual-screening pipelines in modern drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationDrug DesignArtificial IntelligenceWorkflowDrug DiscoveryLigandsSoftwareHumansBinding Sites

Stichwörter der Autor:innen

artificial intelligencemolecular dockingopen-source softwarereproducible workflowsstructure-based drug designvirtual screening

Substanzen

Ligands

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia.

ORCID-Profile: Faizul Azam

Förderung

  • Deanship of Graduate Studies and Scientific Research at Qassim University

Zitieren

APA

Azam, F., & Almahmoud, S. A. (2026). Open-Source Molecular Docking and AI-Augmented Structure-Based Drug Design: Current Workflows, Challenges, and Opportunities. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27073302

Vancouver

Azam F, Almahmoud SA. Open-Source Molecular Docking and AI-Augmented Structure-Based Drug Design: Current Workflows, Challenges, and Opportunities. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27073302

BibTeX
@article{Azam2026,
  author = {Azam, Faizul and Almahmoud, Suliman A},
  title = {Open-Source Molecular Docking and AI-Augmented Structure-Based Drug Design: Current Workflows, Challenges, and Opportunities},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27073302}
}
Kostenlos starten →